Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome

Table 2

Prevalence of insulin resistance in 250 Thai women with polycystic ovary syndrome.

Insulin resistance^†	Prevalence
	𝑛	% (95% CI)
Overall	50	20.0 (15.04–24.96)
Impaired fasting glucose (IFG)^‡	8	3.2 (1.02–5.38)
Impaired glucose tolerance (IGT)	34	13.6 (9.35–17.85)
Diabetes mellitus (DM)	14	5.6 (2.75–8.45)
Fasting plasma glucose ≥ 126 mg/dL	9	3.6 (1.29–5.91)
2 hr glucose ≥ 200 mg/dL	13	5.2 (2.45–7.95)
Combined abnormalities	8	3.2 (1.02–5.38)

^†Insulin resistance: impaired fasting glucose (fasting plasma glucose ≥100 and <126 mg/dL), impaired glucose tolerance test (2-hr glucose ≥140 and <200 mg/dL), or the presence of diabetes mellitus.
^‡4 women had combined IFG and IGT and 2 women had combined IFG and 2 hr glucose ≥200 mg/dL.
CI: confidence interval.